TPCW
ZBH icon

TD Private Client Wealth’s Zimmer Biomet ZBH Stock Holding History

TD Private Client Wealth’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.3K Buy
178
+57
+47% +$5K ﹤0.01% 1071
2026
Q1 		$10.9K Sell
121
-1,031
-89% -$94.6K ﹤0.01% 1090
2025
Q4 		$104K Buy
1,152
+153
+15% +$14.5K ﹤0.01% 756
2025
Q3 		$98.4K Buy
999
+123
+14% +$12.2K ﹤0.01% 750
2025
Q2 		$79.9K Sell
876
-35
-4% -$3.38K ﹤0.01% 767
2025
Q1 		$103K Buy
911
+768
+537% +$82.2K ﹤0.01% 703
2024
Q4 		$15.1K Sell
143
-30
-17% -$3.22K ﹤0.01% 1012
2024
Q3 		$18.7K Sell
173
-21
-11% -$2.29K ﹤0.01% 978
2024
Q2 		$21.1K Buy
194
+9
+5% +$1.06K ﹤0.01% 944
2024
Q1 		$24.4K Sell
185
-5,284
-97% -$660K ﹤0.01% 924
2023
Q4 		$666K Sell
5,469
-565
-9% -$63K 0.02% 394
2023
Q3 		$677K Sell
6,034
-1,216
-17% -$154K 0.03% 368
2023
Q2 		$1.06M Sell
7,250
-823
-10% -$112K 0.05% 324
2023
Q1 		$1.04M Sell
8,073
-1,388
-15% -$174K 0.05% 320
2022
Q4 		$1.21M Buy
9,461
+2,941
+45% +$341K 0.06% 292
2022
Q3 		$682K Buy
6,520
+405
+7% +$44.4K 0.03% 364
2022
Q2 		$642K Sell
6,115
-366
-6% -$43.4K 0.03% 383
2022
Q1 		$829K Buy
6,481
+138
+2% +$16.6K 0.04% 363
2021
Q4 		$782K Buy
6,343
+607
+11% +$79.4K 0.03% 366
2021
Q3 		$815K Sell
5,736
-159
-3% -$23.4K 0.03% 347
2021
Q2 		$920K Buy
5,895
+266
+5% +$43.1K 0.04% 335
2021
Q1 		$875K Buy
5,629
+1,736
+45% +$269K 0.04% 327
2020
Q4 		$582K Buy
3,893
+965
+33% +$136K 0.03% 356
2020
Q3 		$387K Sell
2,928
-130
-4% -$17K 0.02% 386
2020
Q2 		$354K Sell
3,058
-1,446
-32% -$167K 0.02% 390
2020
Q1 		$442K Sell
4,504
-1,217
-21% -$160K 0.03% 336
2019
Q4 		$831K Buy
+5,721
New +$790K 0.05% 288

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

TD Private Client Wealth's ZBH Position: Q2 2026 in Review

TD Private Client Wealth increased its Zimmer Biomet (ZBH) stake by 47% in Q2 2026, buying an estimated $5K and bringing the position to 178 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1071.

TD Private Client Wealth first reported a position in ZBH in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.21M in Q4 2022. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • TD Private Client Wealth held 178 shares of Zimmer Biomet worth $15.3K as of Q2 2026.
  • TD Private Client Wealth bought 57 Zimmer Biomet shares in Q2 2026, an estimated $5K.
  • Zimmer Biomet made up ﹤0.01% of TD Private Client Wealth's portfolio in Q2 2026, its #1071 holding.
  • TD Private Client Wealth first reported a position in Zimmer Biomet in Q4 2019 and has held it in 27 quarters since.
  • TD Private Client Wealth's Zimmer Biomet position peaked at $1.21M in Q4 2022.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.